Item 1.01
|
Entry Into a Material Definitive Agreement
|
On September 17, 2019, Translate Bio, Inc. (the Company) entered into an underwriting agreement (the Underwriting Agreement) with
Citigroup Global Markets Inc., Jefferies LLC and SVB Leerink LLC, as underwriters (the Underwriters), relating to an underwritten public offering (the Offering) of 9,000,000 shares (the Shares) of the
Companys common stock, par value $0.001 per share (the Common Stock). All of the Shares are being sold by the Company. The price to the public in the Offering is $10.00 per share, and the Underwriters have agreed to purchase the
Shares from the Company pursuant to the Underwriting Agreement at a price of $9.40 per share. Under the terms of the Underwriting Agreement, the Company granted the Underwriters an option, exercisable for 30 days, to purchase up to an additional
1,350,000 shares of Common Stock (the Additional Shares) at the same price per share as the Shares.
The Company estimates that the net
proceeds from the Offering will be approximately $84.2 million, or approximately $96.9 million if the Underwriters exercise in full their option to purchase Additional Shares, in each case after deducting underwriting discounts and
commissions and estimated offering expenses.
The Shares, and any Additional Shares, will be issued pursuant to a prospectus supplement dated September
17, 2019 and an accompanying base prospectus that form a part of the registration statement on Form S-3 that the Company filed with the Securities and Exchange Commission (SEC) (File No. 333-232543). The closing of the Offering is expected to take place on or about September 20, 2019, subject to the satisfaction of customary closing conditions.
The Underwriting Agreement contains customary representations, warranties, covenants and agreements by the Company, customary conditions to closing,
indemnification obligations of the Company and the Underwriters, including for liabilities under the Securities Act of 1933, as amended, other obligations of the parties and termination provisions. The representations, warranties and covenants
contained in the Underwriting Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement, and may be subject to limitations agreed upon by the contracting parties. A
copy of the Underwriting Agreement is attached as Exhibit 1.1 hereto and is incorporated herein by reference. The foregoing description of the material terms of the Underwriting Agreement does not purport to be complete and is qualified in its
entirety by reference to such exhibit.
A copy of the legal opinion and consent of Wilmer Cutler Pickering Hale and Dorr LLP relating to the Shares and
the Additional Shares is attached as Exhibit 5.1 hereto.